 |
Rezafungin |
|---|---|
| Trade Name | |
| Orphan Indication | Candidemia and invasive candidiasis infections caused by susceptible Candida spp |
| USA Market Approval | USA |
| USA Designation Date | 2016-02-08 00:00:00 |
| Sponsor | Cidara Therapeutics, Inc.;6310 Nancy Ridge Drive, Suite 101;San Diego, California, 92121 |
